ALLIANCEBERNSTEIN L.P. - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$61,000
+29.8%
23,500
-17.8%
0.00%
Q4 2018$47,000
-73.4%
28,600
-21.6%
0.00%
Q3 2018$177,000
-22.4%
36,5000.0%0.00%
Q2 2018$228,000
-7.3%
36,500
+23.3%
0.00%
Q1 2018$246,000
-18.5%
29,6000.0%0.00%
Q4 2017$302,000
+50.2%
29,600
+34.5%
0.00%
Q3 2017$201,000
+24.8%
22,0000.0%0.00%
Q2 2017$161,00022,0000.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders